The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Protection Against Vaginal SIV Transmission with Microencapsulated Vaccine
Abstract
Although protection in animal models against intravenous challenges with simian immunodeficiency virus (SIV) has been reported, no previous vaccines have protected against a heterosexual route of infection. In this study, five of six macaques were protected against vaginal challenge when immunized with formalin-treated SIV in biodegradable microspheres by the intramuscular plus oral or plus intratracheal route. Oral immunization alone did not protect. After a second vaginal challenge, three of four intramuscularly primed and mucosally boosted macaques remained protected. The data suggest that protection against human immunodeficiency virus vaginal transmission could be provided by microsphere-based booster vaccines when used to immunize women who are systemically primed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef Gene
Daniel, M. D., Kirchhoff, F., Czajak, S. C., Sehgal, P. K., & Desrosiers, R. C. (1992) · Science · doi:10.1126/science.1470917 · Cited by 1,015
Mestecky, J., & Mcghee, J. R. (1987) · Advances in Immunology · doi:10.1016/s0065-2776(08)60240-0 · Cited by 946
Mestecky, J. (1987) · Journal of Clinical Immunology · doi:10.1007/bf00915547 · Cited by 816
McDermott, M. R., & Bienenstock, J. (1979) · PubMed · Cited by 733
Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M., & Tice, T. R. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90133-e · Cited by 689
Self-citationBerman, P. W., Gregory, T. J., Riddle, L., Nakamura, G. R., Champe, M. A., Porter, J. P., Wurm, F. M., Hershberg, R. D., Cobb, E. K., & Eichberg, J. W. (1990) · Nature · doi:10.1038/345622a0 · Cited by 590
Cellular Proteins Bound to Immunodeficiency Viruses: Implications for Pathogenesis and Vaccines
Arthur, L. O., Bess, J. W., Sowder, R. C., Benveniste, R. E., Mann, D. L., Chermann, J.-C., & Henderson, L. E. (1992) · Science · doi:10.1126/science.1470916 · Cited by 559
Evidence for a Common Mucosal Immunologic System
McDermott, M. R., & Bienenstock, J. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.122.5.1892 · Cited by 446
Immunoglobulin A: Strategic Defense Initiative at the Mucosal Surface
Underdown, B. (1986) · Annual Review of Immunology · doi:10.1146/annurev.immunol.4.1.389 · Cited by 414
Biodegradable microspheres as a vaccine delivery system
Eldridge, J. H., Staas, J. K., Meulbroek, J. A., McGhee, J. R., Tice, T. R., & Gilley, R. M. (1991) · Molecular Immunology · doi:10.1016/0161-5890(91)90076-v · Cited by 399
Self-citationOgra, P. L., Karzon, D. T., Righthand, F., & MacGillivray, M. (1968) · New England Journal of Medicine · doi:10.1056/nejm196810242791701 · Cited by 397
AIDS: an International Perspective
Piot, P., Plummer, F. A., Mhalu, F. S., Lamboray, J.-L., Chin, J., & Mann, J. M. (1988) · Science · doi:10.1126/science.3277271 · Cited by 387
Eldridge, J. H., Staas, J. K., Meulbroek, J. A., Tice, T. R., & Gilley, R. M. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.2978-2986.1991 · Cited by 368
Self-citationImmunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
Girard, M., Kieny, M. P., Pinter, A., Barre-Sinoussi, F., Nara, P., Kolbe, H., Kusumi, K., Chaput, A., Reinhart, T., & Muchmore, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.542 · Cited by 352
Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160
Hu, S.-L., Abrams, K., Barber, G. N., Moran, P., Zarling, J. M., Langlois, A. J., Kuller, L., Morton, W. R., & Benveniste, R. E. (1992) · Science · doi:10.1126/science.1531159 · Cited by 335
Vaccine protection against simian immunodeficiency virus infection.
Desrosiers, R. C., Wyand, M. S., Kodama, T., Ringler, D. J., Arthur, L. O., Sehgal, P. K., Letvin, N. L., King, N. W., & Daniel, M. D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6353 · Cited by 313
Miller, C. J., Alexander, N. J., Sutjipto, S., Lackner, A. A., Gettie, A., Hendrickx, A. G., Lowenstine, L. J., Jennings, M., & Marx, P. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4277-4284.1989 · Cited by 283
Self-citationBiodegradable Microspheres: Vaccine Delivery System for Oral Immunization
Eldridge, J. H., Gilley, R. M., Staas, J. K., Moldoveanu, Z., Meulbroek, J. A., & Tice, T. R. (1989) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-74529-4_6 · Cited by 191
Self-citationStott, E. J., Taffs, F., Kitchin, P., Chan, W. L., Mills, K., Page, M., Cranage, M., & Greenaway, P. (1990) · The Lancet · doi:10.1016/0140-6736(90)93310-l · Cited by 170
Controlled release microparticles for vaccine development
O’Hagan, D. T., Jeffery, H., Roberts, M. J. J., McGee, J. P., & Davis, S. S. (1991) · Vaccine · doi:10.1016/0264-410x(91)90295-h · Cited by 149
A Recombinant Human Adenovirus Vaccine against Rabies
PREVEC, L., Campbell, J. B., Christie, B. S., Belbeck, L. W., & Graham, F. L. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.1.27 · Cited by 148
Microparticles as potentially orally active immunological adjuvants
O’Hagan, D. T., Palin, K. J., Davis, S. S., Artursson, P., & Sjöholm, I. (1989) · Vaccine · doi:10.1016/0264-410x(89)90156-4 · Cited by 115
Immunoglobulin levels and antibody to Candida albicans in human cervicovaginal secretions.
Waldman, R. H., Cruz, J. M., & Rowe, D. S. (1972) · PubMed · Cited by 97
Fuhrman, J. A., & Cebra, J. J. (1981) · The Journal of Experimental Medicine · doi:10.1084/jem.153.3.534 · Cited by 94
Poly (butyl-2-cyanoacrylate) particles as adjuvants for oral immunization
O’Hagan, D. T., Palin, K. J., & Davis, S. S. (1989) · Vaccine · doi:10.1016/0264-410x(89)90231-4 · Cited by 71
Silverman, S., Jagdis, F., Hoeprich, P. D., Merten, D., & Morgan, J. P. (1982) · Veterinary Radiology · doi:10.1111/j.1740-8261.1982.tb01295.x · Cited by 67
Jackson, S., Mestecky, J. F., Childers, N. K., & Michalek, S. M. (1990) · Infection and Immunity · doi:10.1128/iai.58.6.1932-1936.1990 · Cited by 63
PREVEC, L., Bs, C., Ke, L., Mm, B., Fl, G., & Rosenthal, K. L. (1991) · PubMed · Cited by 58
Biodegradable poly(dl-lactide-co-glycolide) microspheres
Eldridge, J. H., Staas, J. K., Tice, T. R., & Gilley, R. M. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80069-w · Cited by 31
Self-citation
Cited by
Protein release from alginate matrices
Gombotz, W. R., & Wee, S. F. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.007 · Cited by 1,609
Protein release from alginate matrices
Gombotz, W. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00124-5 · Cited by 1,550
Vaccine adjuvants: Current state and future trends
Petrovsky, N., & Aguilar, J. C. (2004) · Immunology & Cell Biology · doi:10.1111/j.0818-9641.2004.01272.x · Cited by 1,005
Biodegradable microspheres for protein delivery
Sinha, V. R., & Trehan, A. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00194-9 · Cited by 814
Spira, A. I., Marx, P. A., Patterson, B. K., Mahoney, J., Koup, R. A., Wolinsky, S. M., & Ho, D. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.215 · Cited by 692
Self-citation
Metadata
- Authors
- Marx, P. A., Compans, R. W., Gettie, A., Staas, J. K., Gilley, R. M., Mulligan, M. J., Yamshchikov, G. V., Chen, D., & Eldridge, J. H.
- Venue
- Science
- Published
- 1993-05-28
- Volume
- 260
- Issue
- 5112
- Pages
- 1323-1327
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2054827263
- Cited by
- 261
- References
- 29
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.